{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:38:45Z","timestamp":1790044725289,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1089"],"award-info":[{"award-number":["SFB 1089"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1089"],"award-info":[{"award-number":["SFB 1089"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1089"],"award-info":[{"award-number":["SFB 1089"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR 2715"],"award-info":[{"award-number":["FOR 2715"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GQ0806"],"award-info":[{"award-number":["01GQ0806"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["EraNet DeCipher"],"award-info":[{"award-number":["EraNet DeCipher"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003390","name":"Fritz Thyssen Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003390","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BONFOR program of the University of Bonn Medical Center"},{"name":"Associazione Paolo Zorzi per le Neuroscienze","award":["EPICARE"],"award-info":[{"award-number":["EPICARE"]}]},{"name":"Italian ministry of Health","award":["Ricerca Corrente and RF151"],"award-info":[{"award-number":["Ricerca Corrente and RF151"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12035-018-1181-y","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T07:08:11Z","timestamp":1529651291000},"page":"1825-1840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Anti-epileptogenic and Anti-convulsive Effects of Fingolimod in Experimental Temporal Lobe Epilepsy"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6688-4916","authenticated-orcid":false,"given":"Julika","family":"Pitsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Kuehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadym","family":"Gnatkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Alexander","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M. J.","family":"van Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"de Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Vatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian E.","family":"Elger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"issue":"10","key":"1181_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrd4126","volume":"12","author":"W Loscher","year":"2013","unstructured":"Loscher W, Klitgaard H, Twyman RE, Schmidt D (2013) New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 12(10):757\u2013776. \n                    https:\/\/doi.org\/10.1038\/nrd4126","journal-title":"Nat Rev Drug Discov"},{"issue":"9971","key":"1181_CR2","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","volume":"385","author":"SL Moshe","year":"2015","unstructured":"Moshe SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet 385(9971):884\u2013898. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(14)60456-6","journal-title":"Lancet"},{"issue":"5","key":"1181_CR3","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1212\/WNL.51.5.1256","volume":"51","author":"F Semah","year":"1998","unstructured":"Semah F, Picot MC, Adam C, Broglin D, Arzimanoglou A, Bazin B, Cavalcanti D, Baulac M (1998) Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 51(5):1256\u20131262","journal-title":"Neurology"},{"issue":"8","key":"1181_CR4","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1007\/s12035-015-9465-y","volume":"53","author":"AM Johnson","year":"2016","unstructured":"Johnson AM, Sugo E, Barreto D, Hiew CC, Lawson JA, Connolly AM, Somerville E, Hasic E et al (2016) The severity of gliosis in hippocampal sclerosis correlates with pre-operative seizure burden and outcome after temporal lobectomy. Mol Neurobiol 53(8):5446\u20135456. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9465-y","journal-title":"Mol Neurobiol"},{"key":"1181_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2014.12.047","volume":"323","author":"C Steinhauser","year":"2016","unstructured":"Steinhauser C, Grunnet M, Carmignoto G (2016) Crucial role of astrocytes in temporal lobe epilepsy. Neuroscience 323:157\u2013169. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2014.12.047","journal-title":"Neuroscience"},{"key":"1181_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nbd.2013.12.006","volume":"64","author":"K Ryan","year":"2014","unstructured":"Ryan K, Liang LP, Rivard C, Patel M (2014) Temporal and spatial increase of reactive nitrogen species in the kainate model of temporal lobe epilepsy. Neurobiol Dis 64:8\u201315. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2013.12.006","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1181_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s13311-014-0257-2","volume":"11","author":"A Pitkanen","year":"2014","unstructured":"Pitkanen A, Engel J Jr (2014) Past and present definitions of epileptogenesis and its biomarkers. Neurotherapeutics 11(2):231\u2013241. \n                    https:\/\/doi.org\/10.1007\/s13311-014-0257-2","journal-title":"Neurotherapeutics"},{"issue":"2","key":"1181_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s13311-014-0266-1","volume":"11","author":"RM Kaminski","year":"2014","unstructured":"Kaminski RM, Rogawski MA, Klitgaard H (2014) The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics 11(2):385\u2013400. \n                    https:\/\/doi.org\/10.1007\/s13311-014-0266-1","journal-title":"Neurotherapeutics"},{"issue":"11","key":"1181_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s40265-016-0603-2","volume":"76","author":"HC Tsai","year":"2016","unstructured":"Tsai HC, Han MH (2016) Sphingosine-1-phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation. Drugs 76(11):1067\u20131079. \n                    https:\/\/doi.org\/10.1007\/s40265-016-0603-2","journal-title":"Drugs"},{"key":"1181_CR10","unstructured":"Paxinos G, Franklin, K (2012) Paxinos and Franklin\u2019s the mouse brain in stereotaxic coordinates, 4th edition."},{"issue":"Pt 5","key":"1181_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/brain\/awv067","volume":"138","author":"P Bedner","year":"2015","unstructured":"Bedner P, Dupper A, Huttmann K, Muller J, Herde MK, Dublin P, Deshpande T, Schramm J et al (2015) Astrocyte uncoupling as a cause of human temporal lobe epilepsy. Brain 138(Pt 5):1208\u20131222. \n                    https:\/\/doi.org\/10.1093\/brain\/awv067","journal-title":"Brain"},{"issue":"49","key":"1181_CR12","doi-asserted-by":"publisher","first-page":"13341","DOI":"10.1523\/JNEUROSCI.1421-08.2008","volume":"28","author":"AJ Becker","year":"2008","unstructured":"Becker AJ, Pitsch J, Sochivko D, Opitz T, Staniek M, Chen CC, Campbell KP, Schoch S et al (2008) Transcriptional upregulation of Cav3.2 mediates epileptogenesis in the pilocarpine model of epilepsy. J Neurosci 28(49):13341\u201313353. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1421-08.2008","journal-title":"J Neurosci"},{"issue":"3","key":"1181_CR13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.nbd.2007.03.003","volume":"26","author":"J Pitsch","year":"2007","unstructured":"Pitsch J, Schoch S, Gueler N, Flor PJ, van der Putten H, Becker AJ (2007) Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy. Neurobiol Dis 26(3):623\u2013633","journal-title":"Neurobiol Dis"},{"issue":"36","key":"1181_CR14","doi-asserted-by":"publisher","first-page":"12384","DOI":"10.1523\/JNEUROSCI.0223-12.2012","volume":"32","author":"J Pitsch","year":"2012","unstructured":"Pitsch J, Opitz T, Borm V, Woitecki A, Staniek M, Beck H, Becker AJ, Schoch S (2012) The presynaptic active zone protein RIM1alpha controls epileptogenesis following status epilepticus. J Neurosci 32(36):12384\u201312395. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0223-12.2012","journal-title":"J Neurosci"},{"key":"1181_CR15","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/epi.13795","volume":"58","author":"J Pitsch","year":"2017","unstructured":"Pitsch J, Becker AJ, Schoch S, Muller JA, de Curtis M, Gnatkovsky V (2017) Circadian clustering of spontaneous epileptic seizures emerges after pilocarpine-induced status epilepticus. Epilepsia 58:1159\u20131171. \n                    https:\/\/doi.org\/10.1111\/epi.13795","journal-title":"Epilepsia"},{"issue":"2","key":"1181_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.pbb.2012.08.025","volume":"103","author":"F Gao","year":"2012","unstructured":"Gao F, Liu Y, Li X, Wang Y, Wei D, Jiang W (2012) Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model. Pharmacol Biochem Behav 103(2):187\u2013196. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2012.08.025","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"1181_CR17","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1007\/s13311-017-0550-y","volume":"14","author":"A Leo","year":"2017","unstructured":"Leo A, Citraro R, Amodio N, De Sarro C, Gallo Cantafio ME, Constanti A, De Sarro G, Russo E (2017) Fingolimod exerts only temporary antiepileptogenic effects but longer-lasting positive effects on behavior in the WAG\/Rij rat absence epilepsy model. Neurotherapeutics 14(4):1134\u20131147. \n                    https:\/\/doi.org\/10.1007\/s13311-017-0550-y","journal-title":"Neurotherapeutics"},{"issue":"3","key":"1181_CR18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659\u2013661. \n                    https:\/\/doi.org\/10.1096\/fj.07-9574LSF","journal-title":"FASEB J"},{"issue":"3","key":"1181_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-006-0187-0","volume":"113","author":"I Bl\u00fcmcke","year":"2007","unstructured":"Bl\u00fcmcke I, Pauli E, Clusmann H, Schramm J, Becker A, Elger C, Merschhemke M, Meencke HJ et al (2007) A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol 113(3):235\u2013244. \n                    https:\/\/doi.org\/10.1007\/s00401-006-0187-0","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1181_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1055\/s-2002-35826","volume":"63","author":"T Kral","year":"2002","unstructured":"Kral T, Clusmann H, Urbach J, Schramm J, Elger CE, Kurthen M, Grunwald T (2002) Preoperative evaluation for epilepsy surgery (Bonn algorithm). Zentralbl Neurochir 63(3):106\u2013110","journal-title":"Zentralbl Neurochir"},{"key":"1181_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9688","volume":"6","author":"KM Loo van","year":"2015","unstructured":"van Loo KM, Schaub C, Pitsch J, Kulbida R, Opitz T, Ekstein D, Dalal A, Urbach H et al (2015) Zinc regulates a key transcriptional pathway for epileptogenesis via metal-regulatory transcription factor 1. Nat Commun 6:8688. \n                    https:\/\/doi.org\/10.1038\/ncomms9688","journal-title":"Nat Commun"},{"issue":"8","key":"1181_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.seizure.2013.04.023","volume":"22","author":"K Pernhorst","year":"2013","unstructured":"Pernhorst K, Herms S, Hoffmann P, Cichon S, Schulz H, Sander T, Schoch S, Becker AJ et al (2013) TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissue. Seizure 22(8):675\u2013678. \n                    https:\/\/doi.org\/10.1016\/j.seizure.2013.04.023","journal-title":"Seizure"},{"issue":"12","key":"1181_CR23","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1111\/epi.13218","volume":"56","author":"RT Jones","year":"2015","unstructured":"Jones RT, Barth AM, Ormiston LD, Mody I (2015) Evolution of temporal and spectral dynamics of pathologic high-frequency oscillations (pHFOs) during epileptogenesis. Epilepsia 56(12):1879\u20131889. \n                    https:\/\/doi.org\/10.1111\/epi.13218","journal-title":"Epilepsia"},{"issue":"9","key":"1181_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrd4099","volume":"12","author":"GT Kunkel","year":"2013","unstructured":"Kunkel GT, Maceyka M, Milstien S, Spiegel S (2013) Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov 12(9):688\u2013702. \n                    https:\/\/doi.org\/10.1038\/nrd4099","journal-title":"Nat Rev Drug Discov"},{"key":"1181_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejps.2016.09.016","volume":"96","author":"M Gol","year":"2017","unstructured":"Gol M, Ghorbanian D, Hassanzadeh S, Javan M, Mirnajafi-Zadeh J, Ghasemi-Kasman M (2017) Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model. Eur J Pharm Sci 96:72\u201383. \n                    https:\/\/doi.org\/10.1016\/j.ejps.2016.09.016","journal-title":"Eur J Pharm Sci"},{"key":"1181_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/nan.12451","volume":"44","author":"AJ Becker","year":"2017","unstructured":"Becker AJ (2017) Animal models of acquired epilepsy: insights into mechanisms of human epileptogenesis. Neuropathol Appl Neurobiol 44:112\u2013129. \n                    https:\/\/doi.org\/10.1111\/nan.12451","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9","key":"1181_CR27","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S1474-4422(13)70175-3","volume":"12","author":"I Blumcke","year":"2013","unstructured":"Blumcke I, Cross JH, Spreafico R (2013) The international consensus classification for hippocampal sclerosis: an important step towards accurate prognosis. Lancet Neurol 12(9):844\u2013846. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(13)70175-3","journal-title":"Lancet Neurol"},{"issue":"Suppl 3","key":"1181_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1528-1167.2011.03033.x","volume":"52","author":"E Aronica","year":"2011","unstructured":"Aronica E, Crino PB (2011) Inflammation in epilepsy: clinical observations. Epilepsia 52(Suppl 3):26\u201332. \n                    https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03033.x","journal-title":"Epilepsia"},{"issue":"1","key":"1181_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1586\/14737175.2016.1123094","volume":"16","author":"DR Jeffery","year":"2016","unstructured":"Jeffery DR, Rammohan KW, Hawker K, Fox E (2016) Fingolimod: a review of its mode of action in the context of its efficacy and safety profile in relapsing forms of multiple sclerosis. Expert Rev Neurother 16(1):31\u201344. \n                    https:\/\/doi.org\/10.1586\/14737175.2016.1123094","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"1181_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171552","volume":"12","author":"DH Lee","year":"2017","unstructured":"Lee DH, Seubert S, Huhn K, Brecht L, Rotger C, Waschbisch A, Schlachetzki J, Klausmeyer A et al (2017) Fingolimod effects in neuroinflammation: regulation of astroglial glutamate transporters? PLoS One 12(3):e0171552. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0171552","journal-title":"PLoS One"},{"issue":"8","key":"1181_CR31","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1073\/pnas.1615413114","volume":"114","author":"V Rothhammer","year":"2017","unstructured":"Rothhammer V, Kenison JE, Tjon E, Takenaka MC, de Lima KA, Borucki DM, Chao CC, Wilz A et al (2017) Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation. Proc Natl Acad Sci U S A 114(8):2012\u20132017. \n                    https:\/\/doi.org\/10.1073\/pnas.1615413114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1181_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.03.034","volume":"119","author":"A Das","year":"2017","unstructured":"Das A, Arifuzzaman S, Kim SH, Lee YS, Jung KH, Chai YG (2017) FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing. Neuropharmacology 119:1\u201314. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2017.03.034","journal-title":"Neuropharmacology"},{"issue":"6","key":"1181_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1474-4422(14)70049-3","volume":"13","author":"PA Calabresi","year":"2014","unstructured":"Calabresi PA, Radue EW, Goodin D, Jeffery D, Rammohan KW, Reder AT, Vollmer T, Agius MA et al (2014) Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Neurol 13(6):545\u2013556. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(14)70049-3","journal-title":"Lancet Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1181-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1181-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1181-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T05:45:08Z","timestamp":1569131108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1181-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1181"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1181-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733499501.793548925","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"23 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}